Logo image of 1PHIA.MI

KONINKLIJKE PHILIPS NV (1PHIA.MI) Stock Fundamental Analysis

Europe - BIT:1PHIA - NL0000009538 - Common Stock

24.02 EUR
+0.7 (+3%)
Last: 9/12/2025, 7:00:00 PM
Fundamental Rating

3

1PHIA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 59 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of 1PHIA have multiple concerns. 1PHIA has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year 1PHIA was profitable.
1PHIA had a positive operating cash flow in the past year.
In multiple years 1PHIA reported negative net income over the last 5 years.
1PHIA had a positive operating cash flow in 4 of the past 5 years.
1PHIA.MI Yearly Net Income VS EBIT VS OCF VS FCF1PHIA.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

1.2 Ratios

1PHIA's Return On Assets of 0.61% is on the low side compared to the rest of the industry. 1PHIA is outperformed by 61.02% of its industry peers.
The Return On Equity of 1PHIA (1.56%) is worse than 61.02% of its industry peers.
1PHIA has a Return On Invested Capital of 4.27%. This is comparable to the rest of the industry: 1PHIA outperforms 44.07% of its industry peers.
Industry RankSector Rank
ROA 0.61%
ROE 1.56%
ROIC 4.27%
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1PHIA.MI Yearly ROA, ROE, ROIC1PHIA.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

Looking at the Profit Margin, with a value of 0.91%, 1PHIA is doing worse than 62.71% of the companies in the same industry.
1PHIA has a Operating Margin of 6.11%. This is comparable to the rest of the industry: 1PHIA outperforms 44.07% of its industry peers.
1PHIA's Operating Margin has declined in the last couple of years.
The Gross Margin of 1PHIA (43.85%) is worse than 69.49% of its industry peers.
In the last couple of years the Gross Margin of 1PHIA has remained more or less at the same level.
Industry RankSector Rank
OM 6.11%
PM (TTM) 0.91%
GM 43.85%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
1PHIA.MI Yearly Profit, Operating, Gross Margins1PHIA.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

2

2. Health

2.1 Basic Checks

1PHIA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for 1PHIA has been reduced compared to 1 year ago.
1PHIA has more shares outstanding than it did 5 years ago.
1PHIA has a worse debt/assets ratio than last year.
1PHIA.MI Yearly Shares Outstanding1PHIA.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
1PHIA.MI Yearly Total Debt VS Total Assets1PHIA.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

1PHIA has an Altman-Z score of 1.93. This is not the best score and indicates that 1PHIA is in the grey zone with still only limited risk for bankruptcy at the moment.
1PHIA has a Altman-Z score (1.93) which is in line with its industry peers.
The Debt to FCF ratio of 1PHIA is 19.41, which is on the high side as it means it would take 1PHIA, 19.41 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of 1PHIA (19.41) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.69 indicates that 1PHIA is somewhat dependend on debt financing.
The Debt to Equity ratio of 1PHIA (0.69) is worse than 72.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 19.41
Altman-Z 1.93
ROIC/WACC0.68
WACC6.25%
1PHIA.MI Yearly LT Debt VS Equity VS FCF1PHIA.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

1PHIA has a Current Ratio of 1.26. This is a normal value and indicates that 1PHIA is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.26, 1PHIA is not doing good in the industry: 69.49% of the companies in the same industry are doing better.
A Quick Ratio of 0.81 indicates that 1PHIA may have some problems paying its short term obligations.
With a Quick ratio value of 0.81, 1PHIA is not doing good in the industry: 66.10% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.81
1PHIA.MI Yearly Current Assets VS Current Liabilites1PHIA.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

4

3. Growth

3.1 Past

1PHIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.17%, which is quite good.
1PHIA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.17% yearly.
Looking at the last year, 1PHIA shows a decrease in Revenue. The Revenue has decreased by -1.53% in the last year.
The Revenue has been growing slightly by 1.00% on average over the past years.
EPS 1Y (TTM)11.17%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%21.91%
Revenue 1Y (TTM)-1.53%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-2.12%

3.2 Future

Based on estimates for the next years, 1PHIA will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.33% on average per year.
1PHIA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.97% yearly.
EPS Next Y1.18%
EPS Next 2Y6.04%
EPS Next 3Y8.31%
EPS Next 5Y12.33%
Revenue Next Year-1.51%
Revenue Next 2Y0.97%
Revenue Next 3Y2.19%
Revenue Next 5Y2.97%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1PHIA.MI Yearly Revenue VS Estimates1PHIA.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
1PHIA.MI Yearly EPS VS Estimates1PHIA.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

1PHIA is valuated correctly with a Price/Earnings ratio of 16.68.
88.14% of the companies in the same industry are more expensive than 1PHIA, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.20. 1PHIA is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 15.42, 1PHIA is valued correctly.
1PHIA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. 1PHIA is cheaper than 77.97% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of 1PHIA to the average of the S&P500 Index (22.70), we can say 1PHIA is valued slightly cheaper.
Industry RankSector Rank
PE 16.68
Fwd PE 15.42
1PHIA.MI Price Earnings VS Forward Price Earnings1PHIA.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1PHIA is valued a bit cheaper than the industry average as 76.27% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1PHIA is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 53.29
EV/EBITDA 12.46
1PHIA.MI Per share data1PHIA.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)14.09
PEG (5Y)N/A
EPS Next 2Y6.04%
EPS Next 3Y8.31%

0

5. Dividend

5.1 Amount

1PHIA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

KONINKLIJKE PHILIPS NV

BIT:1PHIA (9/12/2025, 7:00:00 PM)

24.02

+0.7 (+3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)11-04 2025-11-04
Inst Owners42.8%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap23.13B
Analysts75.38
Price Target27.36 (13.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP0.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.64%
Min EPS beat(2)22.24%
Max EPS beat(2)31.04%
EPS beat(4)2
Avg EPS beat(4)6.19%
Min EPS beat(4)-16.56%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-1.09%
EPS beat(12)5
Avg EPS beat(12)15.29%
EPS beat(16)5
Avg EPS beat(16)3.51%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.05%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)2
Avg Revenue beat(12)-1.61%
Revenue beat(16)2
Avg Revenue beat(16)-1.84%
PT rev (1m)4.89%
PT rev (3m)-4.28%
EPS NQ rev (1m)-4.66%
EPS NQ rev (3m)-14%
EPS NY rev (1m)-7.96%
EPS NY rev (3m)-7.96%
Revenue NQ rev (1m)-3.09%
Revenue NQ rev (3m)-6.03%
Revenue NY rev (1m)-2.62%
Revenue NY rev (3m)-2.62%
Valuation
Industry RankSector Rank
PE 16.68
Fwd PE 15.42
P/S 1.3
P/FCF 53.29
P/OCF 21.05
P/B 2.23
P/tB N/A
EV/EBITDA 12.46
EPS(TTM)1.44
EY6%
EPS(NY)1.56
Fwd EY6.48%
FCF(TTM)0.45
FCFY1.88%
OCF(TTM)1.14
OCFY4.75%
SpS18.54
BVpS10.78
TBVpS-1.76
PEG (NY)14.09
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.61%
ROE 1.56%
ROCE 5.69%
ROIC 4.27%
ROICexc 4.72%
ROICexgc 15.5%
OM 6.11%
PM (TTM) 0.91%
GM 43.85%
FCFM 2.43%
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y10.6%
ROICexcg growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score8
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 19.41
Debt/EBITDA 3.01
Cap/Depr 51.35%
Cap/Sales 3.72%
Interest Coverage 4
Cash Conversion 46.06%
Profit Quality 267.9%
Current Ratio 1.26
Quick Ratio 0.81
Altman-Z 1.93
F-Score8
WACC6.25%
ROIC/WACC0.68
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.17%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%21.91%
EPS Next Y1.18%
EPS Next 2Y6.04%
EPS Next 3Y8.31%
EPS Next 5Y12.33%
Revenue 1Y (TTM)-1.53%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-2.12%
Revenue Next Year-1.51%
Revenue Next 2Y0.97%
Revenue Next 3Y2.19%
Revenue Next 5Y2.97%
EBIT growth 1Y476.21%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year50.08%
EBIT Next 3Y20.59%
EBIT Next 5YN/A
FCF growth 1Y3516.67%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y43.47%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%